Arrowgrass Capital Partners (US)’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-275,000
Closed -$913K 196
2013
Q4
$913K Sell
275,000
-850,000
-76% -$2.82M 0.04% 112
2013
Q3
$3.4M Buy
+1,125,000
New +$3.4M 0.13% 101